SEC Company Response from Q (QCLS) — Jun 29, 2017
Q/C TECHNOLOGIES, INC. (QCLS) (CIK 0001321834)
Date: June 29, 2017 · CIK: 0001321834 · Accession: 0001493152-17-007311
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-217390
Letter
AKERS BIOSCIENCES, INC.
GROVE ROAD
THOROFARE, NJ 08086
June 29, 2017
VIA EDGAR
U.S. Securities & Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Re: Akers Biosciences, Inc.
Registration Statement on Form S-3
File No. 333-217390
Ladies and Gentlemen:
In accordance with Rule 461 of the Securities Act of 1933, as amended, Akers Biosciences, Inc. hereby respectfully requests that the effective date of the above-captioned Registration Statement be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on Friday, June 30, 2017, or as soon thereafter as possible.
Very
Truly Yours,
Akers
Biosciences, Inc.
Show Raw Text
CORRESP
1
filename1.htm
AKERS
BIOSCIENCES, INC.
201
GROVE ROAD
THOROFARE,
NJ 08086
June
29, 2017
VIA
EDGAR
U.S.
Securities & Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Akers
Biosciences, Inc.
Registration
Statement on Form S-3
File
No. 333-217390
Ladies
and Gentlemen:
In
accordance with Rule 461 of the Securities Act of 1933, as amended, Akers Biosciences, Inc. hereby
respectfully requests that the effective date of the above-captioned Registration Statement be accelerated
so that it will be declared effective at 4:00 p.m. Eastern Time on Friday, June 30, 2017, or as soon thereafter as possible.
Very
Truly Yours,
Akers
Biosciences, Inc.
/s/
John J. Gormally
John
J. Gormally
Chief
Executive Officer